These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15857317)

  • 1. The function of the extracellular regions in opioid receptor binding: insights from computational biology.
    Paterlini MG
    Curr Top Med Chem; 2005; 5(3):357-67. PubMed ID: 15857317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A.
    Mollereau C; Mouledous L; Lapalu S; Cambois G; Moisand C; Butour JL; Meunier JC
    Mol Pharmacol; 1999 Feb; 55(2):324-31. PubMed ID: 9927625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nociceptin (ORL1) receptor: molecular cloning and functional architecture.
    Meunier J; Mouledous L; Topham CM
    Peptides; 2000 Jul; 21(7):893-900. PubMed ID: 10998522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bremazocine recognizes the difference in four amino acid residues to discriminate between a nociceptin/orphanin FQ receptor and opioid receptors.
    Seki T; Minami M; Kimura C; Uehara T; Nakagawa T; Satoh M
    Jpn J Pharmacol; 1998 Aug; 77(4):301-6. PubMed ID: 9749931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation.
    Daga PR; Zaveri NT
    Proteins; 2012 Aug; 80(8):1948-61. PubMed ID: 22489047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of ligand selectivity at the kappa-receptor based on the structure of the orphanin FQ receptor.
    Owens CE; Akil H
    J Pharmacol Exp Ther; 2002 Mar; 300(3):992-9. PubMed ID: 11861808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different domains of the ORL1 and kappa-opioid receptors are involved in recognition of nociceptin and dynorphin A.
    Lapalu S; Moisand C; Butour JL; Mollereau C; Meunier JC
    FEBS Lett; 1998 May; 427(2):296-300. PubMed ID: 9607332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor.
    Xue JC; Chen C; Zhu J; Kunapuli S; DeRiel JK; Yu L; Liu-Chen LY
    J Biol Chem; 1994 Dec; 269(48):30195-9. PubMed ID: 7982926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the role of extracellular loops of opioid receptors in conferring ligand selectivity.
    Metzger TG; Ferguson DM
    FEBS Lett; 1995 Nov; 375(1-2):1-4. PubMed ID: 7498453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
    Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
    J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.
    Pan YX; Cheng J; Xu J; Rossi G; Jacobson E; Ryan-Moro J; Brooks AI; Dean GE; Standifer KM; Pasternak GW
    Mol Pharmacol; 1995 Jun; 47(6):1180-8. PubMed ID: 7603458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.
    Zaveri NT; Journigan VB; Polgar WE
    ACS Chem Neurosci; 2015 Apr; 6(4):646-57. PubMed ID: 25635572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
    Pogozheva ID; Lomize AL; Mosberg HI
    Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of a nociceptin receptor from zebrafish (Danio rerio).
    Rivas-Boyero AA; Herrero-Turrión MJ; Gonzalez-Nunez V; Sánchez-Simón FM; Barreto-Valer K; Rodríguez RE
    J Mol Endocrinol; 2011 Apr; 46(2):111-23. PubMed ID: 21247980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the structure and function of opioid receptors.
    Law PY; Wong YH; Loh HH
    Biopolymers; 1999; 51(6):440-55. PubMed ID: 10797232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
    Meunier JC
    Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsaicin inhibits the in vitro binding of peptides selective for mu- and kappa-opioid, and nociceptin-receptors.
    Wollemann M; Ioja E; Benyhe S
    Brain Res Bull; 2008 Sep; 77(2-3):136-42. PubMed ID: 18588953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
    Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
    Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor-like 1 (ORL1) molecular "road map" to understanding ligand interaction and selectivity.
    Philip AE; Poupaert JH; McCurdy CR
    Curr Top Med Chem; 2005; 5(3):325-40. PubMed ID: 15857315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene.
    Clarke S; Chen Z; Hsu MS; Pintar J; Hill R; Kitchen I
    Brain Res; 2001 Jul; 906(1-2):13-24. PubMed ID: 11430857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.